In a rat model of intervertebral disc degeneration, MOTS-c injection preserved disc height (82.4% versus 58.7% in the untreated group), restored MRI signals indicating improved disc hydration, and reduced histological degeneration scores by 44% compared to untreated controls
With a production capacity that can be expanded to 3,000 tonnes per year across all product lines, HONGDA can offer affordable prices without sacrificing quality
While the research base for microdosing, specifically, is still developing, and lower-dose protocols are being explored, though clinical evidence for efficacy at sub-therapeutic doses remains limited
NAD+ Injections are an excellent option for individuals looking to support cellular health, increase energy production, and promote healthy aging